IN8bio’s Stock Soars 185.71% on Trial Results for Cancer Therapy

IN8bio, Inc. is at the forefront of developing innovative cancer therapies.

On April 24th, IN8bio’s stock skyrocketed by 185.71%, closing at $3.00.

[{"selector":"#anim-438ebcf2-6f3f-443d-a2e7-4fc9d60fab72","keyframes":[{"offset":0,"transform":"translate3d(0, -141.14058%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.29,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.45,"transform":"translate3d(0, -39.688731096%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.61,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.71,"transform":"translate3d(0, -13.493039448000001%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.8,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.85,"transform":"translate3d(0, -5.066946822%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.92,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.96,"transform":"translate3d(0, -2.201793048%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":1,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"}],"delay":0,"duration":600,"fill":"both"}]

This surge was due to the announcement of new data from their Phase 1 trial of INB-100 in leukemia patients.

[{"selector":"#anim-53516cd3-1470-48c7-b25e-a9fb6e94ed27","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

The results were impressive: 100% of evaluable patients treated with INB-100 remained alive.

[{"selector":"#anim-bafd2d9a-a147-4dbd-86d2-8b7cbd0a4687","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ecf3f813-6e88-4a52-a5d5-3908f5eaba36","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

The company’s stock symbol is INAB and it is traded on the NasdaqGM.

[{"selector":"#anim-2ae2febe-5a8d-49f2-8d64-cf289e0ae0bf","keyframes":{"transform":["scale(1)","scale(1.5)","scale(0.95)","scale(1)"],"offset":[0,0.33,0.66,1]},"delay":0,"duration":1450,"easing":"ease-in-out","fill":"both","iterations":1}]

The company is based in New York City, USA, and was founded in 2016.

[{"selector":"#anim-28ae8ca9-abd1-4c08-a87e-ae8a31eabedf","keyframes":{"transform":["translate3d(99.28058%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-897f0bed-6838-48de-9b33-e734144d057b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a3562d39-2eb3-493c-afef-d6dd7a00a043","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

IN8bio’s success in the stock market reflects its success in developing cutting-edge cancer treatments.

[{"selector":"#anim-4fae8d26-8526-46b3-ab54-1bb2d95931fb","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-75597f92-1cc6-46b9-8c7a-9441fd719394","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

IN8bio, Inc. is a clinical-stage biotechnology company that focuses on developing innovative therapies for the treatment of cancers.

[{"selector":"#anim-4bd5e7f9-040b-4ac1-b35c-7faf03e0cc48","keyframes":{"transform":["translate3d(-98.80953%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7e8e01e0-441d-49f1-a3da-85745509b934","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-4c3df68f-fcee-48d7-a825-6898f677b7fe","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

With a market cap of $74,814,180 and an average volume of 47,897, IN8bio is making waves in the market.

[{"selector":"#anim-6d47ef61-c113-4590-99d0-6b9d3bad082a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6e547b68-6f36-4b57-ba54-2e7f2a77ba5b","keyframes":{"transform":["translate3d(0px, 127.43532%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]